Brasseler, U.S.A. I, L.P. v. Stryker Sales Corporation and Stryker Corporation, Defendants-Cross

182 F.3d 888
CourtCourt of Appeals for the Federal Circuit
DecidedAugust 16, 1999
Docket98-1512, 98-1524
StatusPublished
Cited by50 cases

This text of 182 F.3d 888 (Brasseler, U.S.A. I, L.P. v. Stryker Sales Corporation and Stryker Corporation, Defendants-Cross) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brasseler, U.S.A. I, L.P. v. Stryker Sales Corporation and Stryker Corporation, Defendants-Cross, 182 F.3d 888 (Fed. Cir. 1999).

Opinion

*889 PLAGER, Circuit Judge.

DECISION

Plaintiff Brasseler, U.S.A. I, L.P. (“Brasseler”) appeals a judgment that its U.S. Patent No. 5,306,285 is invalid for violation of the “on sale” bar of 35 U.S.C. § 102(b). The judgment of invalidity was entered by the U.S. District Court for the Southern District of Georgia on motion for summary judgment by Defendants Stryker Sales Corporation and Stryker Corporation (collectively “Stryker”). See Brasseler, U.S.A., I, L.P. v. Stryker Sales Corp., No. CV 497-184 (S.D. Ga. June 25, 1998) (memorandum order).

In ruling on Stryker’s motion for summary judgment of invalidity, the district court additionally held' that Stryker had “abandoned” its claim for attorney fees under 35 U.S.C. § 285 by failing to mention the claim in its motion for summary judgment. Id., slip op. at 10-11. Thereafter the court entered final judgment on all claims. Stryker cross-appeals the dismissal of its claim for attorney fees under § 285.

We affirm the judgment of invalidity, vacate the dismissal of Stryker’s claim for attorney fees, and remand for further proceedings consistent with this opinion.

DISCUSSION

I. On-Sale Bar

We review the district court’s grant of summary judgment of invalidity without deference. See Conroy v. Reebok Iran, Ltd., 14 F.3d 1570, 1575, 29 USPQ2d 1373, 1377 (Fed.Cir.1994). Summary judgment is proper when “there is no genuine issue as to any material fact and ... the moving party is entitled to a judgment as a matter of law.” Fed.R.Civ.P. 56(c). The ultimate determination of whether an invention was on sale within the meaning of § 102(b) is a question of law. See Manville Sales Corp. v. Paramount Sys., Inc., 917 F.2d 544, 549, 16 USPQ2d 1587, 1591 (Fed.Cir.1990).

The patent at issue in this case is directed to surgical saw blades. It is undisputed that prior to the patent’s § 102(b) critical date there was a sale of over three-thousand surgical saw blades embodying the invention set forth in the patent’s claims. The sale was made by DS Manufacturing, Inc., a saw blade manufacturer, to an unincorporated operating division of Plaintiff Brasseler, which sells medical implements including surgical saw blades to hospitals. The district court held that this was a “sale” under § 102(b) and that the patent was therefore invalid.

Brasseler argues that the transaction should be held not to be a § 102(b) sale because of the special facts and circumstances of this case. In particular, Bras-seler points out that joint inventors named on the patent were associated with the buyer (Brasseler) and seller (DS Manufacturing) to the transaction: two of the four named inventors were employed by Bras-seler, one of the named inventors owned DS Manufacturing, and the fourth named inventor was employed by DS Manufacturing. Additionally, Brasseler alleges that it initiated development of the invention, and that at the time of the transaction DS Manufacturing had an arrangement with Brasseler under which DS Manufacturing was obligated to manufacture the patented saw blade solely for Brasseler. Brasseler further alleges that it was the equitable owner of the invention at all times, though the district court found to the contrary and Stryker contests this assertion. Finally, Brasseler points out that before selling the blades to hospitals it performs three further processing steps on the blades, namely, marking, packaging, and sterilization.

In arguing that these facts establish that there was no § 102(b) sale, Brasseler places heavy reliance on our previously used “totality of the circumstances” test under which all of the circumstances surrounding the sale are considered and weighed against the “policies” underlying § 102(b). E.g., Envirotech Corp. v. Wes- *890 tech Eng’g, Inc., 904 F.2d 1571, 1574, 15 USPQ2d 1230, 1232 (Fed.Cir.1990) (citations omitted). Recently, the Supreme Court rejected this test, indicating a preference- for “a definite standard for determining when a patent application must be filed.” Pfaff v. Wells Elecs., Inc., — U.S. -, - & n. 11, 119 S.Ct. 304, 311-12 & n. 11, 142 L.Ed.2d 261 (1998). The Court in Pfaff concluded that the on-sale bar of § 102(b) applies if, prior to the critical date, a product embodying the patented invention was “the subject of a commercial offer for sale .... [, and] the invention [was] ready for patenting.” Id. at 525 U.S. at -, 119 S.Ct. at 311-12.

Since the Pfaff decision, this court has held a patent invalid for violation of the on-sale bar based on “the Supreme Court’s two-part test [enunciated in Pfaff ] without balancing various policies according to the totality of the circumstances as may have been done in the past.” Weatherchem Corp. v. J.L. Clark, Inc., 163 F.3d 1326, 1333, 49 U.S.P.Q.2d 1001, 1006 (Fed.Cir.1998). The present case illustrates the shortcomings of the “totality of the circumstances” test. Indeed, Brasseler’s discussion of this test and the “policies” of § 102(b) displays why the test leads to unpredictable results.

The transaction at issue undisputedly was a “sale” in a commercial law sense. See In re Caveney, 761 F.2d 671, 676, 226 USPQ 1, 4 (Fed.Cir.1985) (“It is well settled that a sale is a contract between parties to give and to pass rights of property for consideration which the buyer pays or promises to pay the seller for the thing bought or sold.”). Furthermore, it is undisputed that the invention was “ready for patenting” at the time of the sale. Pfaff, 525 U.S. at -, 119 S.Ct. at 312.

Brasseler points out that we have recognized that “a sale or offer to sell under 35 U.S.C. § 102(b) must be between two separate entities.” Caveney, 761 F.2d at 676, 226 USPQ at 4. However, Brasseler and DS Manufacturing are clearly separate in a corporate sense: there is no common ownership or control of the two corporate entities. We have held entities separate for purposes of § 102(b) in cases in which there was much more overlap between the buyer and seller than there is here. See id. at 673-74, 676, 761 F.2d 671

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gray v. Koch Foods, Inc.
M.D. Alabama, 2022
Milo & Gabby LLC v. amazon.com, Inc.
693 F. App'x 879 (Federal Circuit, 2017)
Adams v. Bank of America, N.A.
237 F. Supp. 3d 1189 (N.D. Alabama, 2017)
Medicines Company v. Hospira, Inc.
827 F.3d 1363 (Federal Circuit, 2016)
Morton v. Automobile Insurance
102 F. Supp. 3d 1248 (N.D. Alabama, 2015)
Hamilton Beach Brands, Inc. v. Sunbeam Products, Inc.
726 F.3d 1370 (Federal Circuit, 2013)
Mason v. Mitchell's Contracting Service, LLC
816 F. Supp. 2d 1178 (S.D. Alabama, 2011)
Rollins v. ALABAMA COMMUNITY COLLEGE SYSTEM
814 F. Supp. 2d 1250 (M.D. Alabama, 2011)
In Re NTP, Inc.
654 F.3d 1268 (Federal Circuit, 2011)
Grider v. Carver
767 F. Supp. 2d 1246 (M.D. Alabama, 2011)
Crayton v. Valued Services of Alabama, LLC
737 F. Supp. 2d 1320 (M.D. Alabama, 2010)
Askew v. R & L TRANSFER, INC.
676 F. Supp. 2d 1298 (M.D. Alabama, 2009)
Arrow International, Inc. v. Spire Biomedical, Inc.
635 F. Supp. 2d 46 (D. Massachusetts, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
182 F.3d 888, Counsel Stack Legal Research, https://law.counselstack.com/opinion/brasseler-usa-i-lp-v-stryker-sales-corporation-and-stryker-cafc-1999.